SCHEMBL29759019

SCHEMBL29759019

C=CCON(C1CN(C(=O)O)C(CO[Si](C)(C)C(C)(C)C)C=C1C)S(=O)(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 4/20 0.33
MAPT P10636 1/20 0.33
HRAS P01112 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PKM P14618 2/20 0.32
GAA P10253 1/20 0.32
LMNA P02545 3/20 0.31
POLB P06746 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
PTPN1 P18031 1/20 0.30
KDM4E B2RXH2 2/20 0.30
NPSR1 Q6W5P4 2/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28714841 1.00 KMT2A (0.33) KMT2AMEN1ALDH1A1MAPTHRAS
SCHEMBL15320316 0.92 MET (0.33) KMT2AMEN1ALDH1A1MAPTHRAS
SCHEMBL29593959 0.92 MET (0.33) KMT2AMEN1ALDH1A1MAPTHRAS
SCHEMBL16553194 0.92 MET (0.33) KMT2AMEN1ALDH1A1MAPTHRAS
SCHEMBL29759092 0.88 PKM (0.36) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL28696595 0.88 PKM (0.36) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL16553000 0.87 KMT2A (0.33) KMT2AMEN1ALDH1A1MAPTHRAS
SCHEMBL19990061 0.85 MET (0.34) KMT2AMEN1ALDH1A1MAPT
SCHEMBL19990062 0.85 MET (0.34) KMT2AMEN1ALDH1A1MAPT
SCHEMBL19990063 0.85 MET (0.34) KMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512851-B1 BETA-LACTAMASE INHIBITOR COMPOUNDS ENTASIS THERAPEUTICS LTD (GB) 2022-07-06 EP disclosed